These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 12510360

  • 1. [Clinical implication of cyclosporin for rheumatoid arthritis].
    Tanaka Y, Tsujimura S.
    Nihon Rinsho; 2002 Dec; 60(12):2345-50. PubMed ID: 12510360
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
    Schnabel A, Gross WL.
    Dtsch Med Wochenschr; 2003 Jan 24; 128(4):147-9. PubMed ID: 12589584
    [No Abstract] [Full Text] [Related]

  • 5. Combination therapy for rheumatoid arthritis with methotrexate and cyclosporine.
    Pincus T.
    Z Rheumatol; 1998 Feb 24; 57(1):34-6. PubMed ID: 9566105
    [No Abstract] [Full Text] [Related]

  • 6. Influence of longterm therapy with methotrexate and low dose corticosteroids on type 1 and type 2 cytokine production in CD4+ and CD8+ T lymphocytes of patients with rheumatoid arthritis.
    Schuerwegh AJ, van Offel JF, Bridts CH, Stevens WJ, De Clerck LS.
    J Rheumatol; 2001 Aug 24; 28(8):1793-9. PubMed ID: 11508581
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis.
    Tsujimura S, Saito K, Nawata M, Nakayamada S, Tanaka Y.
    Ann Rheum Dis; 2008 Mar 24; 67(3):380-8. PubMed ID: 17660216
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combination drug therapy of seropositive rheumatoid arthritis.
    McCarty DJ, Harman JG, Grassanovich JL, Qian C, Klein JP.
    J Rheumatol; 1995 Sep 24; 22(9):1636-45. PubMed ID: 8523336
    [Abstract] [Full Text] [Related]

  • 13. US consensus guidelines for the use of cyclosporin A in rheumatoid arthritis.
    Cush JJ, Tugwell P, Weinblatt M, Yocum D.
    J Rheumatol; 1999 May 24; 26(5):1176-86. PubMed ID: 10332987
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Relevance of multidrug resistance to rheumatoid arthritis: development of a new therapeutic hypothesis.
    Salmon SE, Dalton WS.
    J Rheumatol Suppl; 1996 Mar 24; 44():97-101. PubMed ID: 8833064
    [Abstract] [Full Text] [Related]

  • 16. Cyclosporine and methotrexate for severe rheumatoid arthritis.
    Malleson P.
    N Engl J Med; 1995 Dec 07; 333(23):1567; author reply 1568-9. PubMed ID: 7477177
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.